China announces ban on technologies using bovine/ovine tissue:
This article was originally published in Clinica
Executive Summary
China has announced that companies must withdraw, before December 31 2006, devices and IVD reagents containing materials from bovine or ovine sources that have direct or indirect contact with the human body. The move is to prevent the spread of bovine spongiform encephalopathy (BSE). The registration certificate of products from countries where BSE is newly found will automatically become invalid and the product cannot be marketed in China. This announcement replaces the one issued on March 22 2002.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.